°²öÎÓéÀÖ¹ÙÍø

³£¼ûÑÛ²¡ÐÂÎÅ

À¼ÖÝ°²öÎÓéÀÖ¹ÙÍøÑÛ¿ÆÒ½ÔºÉ걨µÄ¡¶Ç¿Âö³å¹â¶ÔÊõÔ´ÐÔ¸ÉÑÛÒ½ÖÎ ÆÀ¼Û¡·¿ÎÌâ»ñ2018Äê¶ÈÊм¶¿Æ¼¼ÍýÏëÏîÄ¿Á¢Ïî

×÷ÕߣºÎ´Öª 2018-09-26 15:49:38
×ÖÌå´óС£º

¡¡¡¡¿ËÈÕ£¬À¼ÖÝÊÐ2018Äê¿Æ¼¼¾Ö¿ÆÑÐÍýÏëÏîÄ¿Ðû²¼£¬ÓÉÀ¼ÖÝ°²öÎÓéÀÖ¹ÙÍøÑÛ¿ÆÒ½ÔºÉ걨µÄ¡¶Ç¿Âö³å¹â¶ÔÊõÔ´ÐÔ¸ÉÑÛÒ½ÖÎ ÆÀ¼Û¡·¿ÎÌâ»ñ2018Äê¶ÈÊм¶¿Æ¼¼ÍýÏëÏîÄ¿Á¢Ïî¡£

¡¡¡¡¾ÙÊÀ¸ÉÑÛЭ»á½«¸ÉÑÛ(dry eye disease, DED)½ç˵Ϊ:ÊܶàÒòËØÓ°ÏìµÄÀáĤºÍÑÛ±í¼²²¡,¿Éµ¼ÖÂÑÛ²¿²»ÊÊÖ¢×´,×ÌÈÅÊÓ¹¦Ð§ÒÔ¼°±¬·¢Ó°ÏìÑÛ±íµÄÀáĤ²»ÎȹÌ״̬,°éÓÐÀáÒºÉø͸ѹÔö¸ßºÍÑÛ±íÑ×Ö¢[1]¡£ÎÒ¹ú20ËêÒÔÉÏÈËȺ¸ÉÑÛ»¼²¡ÂÊ30.05%[2]¡£DED ³£¼ûµÄ²¡ÒòÊÇíú°åÏÙ¹¦Ð§ÕÏ°­(meibomain gland dysfunction,MGD)[3]¡£MGDÌåÏÖΪíú°åÏÙµÄÂýÐÔ¡¢ÃÖÂþÐÔÒì³£,ÒÔ×îºóµ¼¹ÜÛձպͻòíú°åÏÙÉø͸ÎïÊýÄ¿»òÖÊÁ¿µÄ¸Ä±äΪÌØÕ÷¡£ÑÇÖÞ¹ú¼ÒÔò¸ß´ï45~70%[4]¡£

¡¡¡¡MGD¶Ô³£¼ûÑÛ²¡µÄÓ°Ï죺(1)MGD¶Ô°×ÄÚÕÏÊõºóÊÓ¾õÖÊÁ¿Ó°Ïì [5]¡£(2)LASIK Êõºó³£±¬·¢²î±ðˮƽ¸ÉÑÛ¡£(3)Òí×´æÀÈâÔÚ±¬·¢Éú³¤Àú³ÌÖвî±ðˮƽÒýÆðíú°åÏÙÌåµÄȱʧ,Ñ×֢״̬µÄÒí×´æÀÈ⻼Õß¿ÉÓ°ÏìíúÖ¬µÄÉø͸¡£

¡¡¡¡MGDµÄ³£¼û²¡Òò£º(1)Öظ´íúÔµÑ×Ö¢¡£Ï¸¾úÌ«¹ý×ÌÉúÐγÉÖÂÃܵÄíúÔµÉúÎïĤ,¸½×ÅÀο¿,ÀÛ¼°½ÞëëÄÒ,ÛÕ±Õíú°åÏÙ,Ôì³É¶ñÐÔÑ­»·¡£(2)MGD»¼Õß½ÞëÈäÐÎòýѬȾÂʸßÓÚÕý·²ÈËȺ,MGD»¼ÕßÖÐÈäÐÎòý¼ì³öÂÊ46.5%,·ÇMGD15.4%[6]¡£(3)½ÇĤ½Ó´¥¾µÏà¹ØÐÔ½áĤÑ×»¼Õßíú°åÏÙÌå·ºÆðŤÇú[7]¡£

¡¡¡¡ÏÖÔÚ,MGDÒ½Öη½·¨°üÀ¨Ò©Îï¡¢ÈÈ·óÓëíú°åÏÙÍÆÄÃ[8],¹ØÓÚÂýÐÔÖÐÖضÈMGD ²»¼Ñ¡£Ç¿Âö³å¹â(intense pulsed light, IPL)Ò½ÖÎMGDµÄÖ÷Òª»úÖÆÓÐ[9]£º(1)¼ÓÈÈÒº»¯íúÖ¬¡£µ±íúÖ¬Êܵ½¸ßÓÚÌåÎÂ4¡æµÄÏà±äζȺó,¿ÉÓɽºÌåת±äΪҺ̬;(2)ïÔÌ­ÉÏƤϸ°ûµÄµòÍöÍÑÂä,½µµÍÏÙÌå¹£ÈûµÄΣº¦;(3)¹âµ÷×÷ÓÃ;(4)»î»¯ÏËάĸϸ°û,ÔöÇ¿½ºÔ­ºÏ³É;(5)¸ù³ýÈäÐÎòý,ïÔ̭ϸ¾ú¸ººÉ;(6)µ÷ÖÆÇ°Ñ×ÐÔϸ°û»îËغͿ¹Ñ×·Ö×ÓµÄÉø͸;(7)ïÔÌ­·´Ó¦ÐÔÑõ»¯Îï¶ÔÑÛ±íµÄ²»Á¼Ó°Ïì¡£

¡¡¡¡Î÷±±µØÇøÌìÆø¸ÉÔï,Ïà¶Ôʪ¶ÈµÍÓÚ45~55%,º£°Î1000~1600Ã×,MGDµÄ±¬·¢ÂʸßÓÚ¶«ÄϵØÇø¡£ÁÙ´²ÉÏÔÚûÓжÔMGDºÏÀíÕïÖεÄÇéÐÎϾÙÐÐÑÛ²¿ÊÖÊõ,µ¼ÖÂÊõÔ´ÐÔ¸ÉÑÛµÄ±È Éý¸ß,ÔöÌíÁË»¼Õß¼°Æä¼ÒÍ¥µÄ¾­¼Ã¼ç¸º¡£À¼ÖÝ°²öÎÓéÀÖ¹ÙÍøÑÛ¿ÆÒ½ÔºËùÉ걨µÄ¡¶Ç¿Âö³å¹â¶ÔÊõÔ´ÐÔ¸ÉÑÛÒ½ÖÎ ÆÀ¼Û¡·¿Æ¼¼ÍýÏëÏîÄ¿Ö÷ÒªÊÇÑо¿£¬Ç¿Âö³å¹â(intense pulsed light, IPL)×÷ΪÏÖÔÚÒ½ÖÎMGDµÄ ÐÂÒªÁ죬¿ÉÒÔսʤ¹Å°åÒ½ÖÎÒªÁìµÄÈõµã£¬¶ø±¾¿ÎÌâµÄ Á¢ÏÒàÒâζ×ÅÎÒÔº¿ÆÑÐÊÂÇéÎȲ½ÏòÇ°¡¢Ò»Ö±ÌáÉý¡£

¡¡¡¡ÕâÊÇÎÒÔº2018Äê»ñµÃµÄµÚ*¸öÊм¶¿ÆÑÐÏîÄ¿£¬ÔÚÏîÄ¿Ñо¿¼°É걨Àú³ÌÖУ¬ÔºÁì*¸ß¶È¹Ø×¢¡¢¶¦Á¦´ó¾ÙÖ§³Ö£¬Îª¿ÎÌâµÄ Á¢ÏîÌṩÁËÇ¿ÓÐÁ¦µÄÖ§³ÖºÍ ¡ £¿ÆÑпÎÌâµÄ Á¢Ï¼ÈÊÇѧÊõ¿ÆÑÐˮƽ½øÒ»²½ÌáÉýµÄÌåÏÖ£¬Ò²ÊÇѧ¿Æ½¨ÉèÉú³¤µÄ½×¶ÎÐÔЧ¹û¡£ÒԺ󣬸ÊËàÖÐÒ½Ò©´óѧÁ¥ÊôÀ¼ÖÝÑÛ¿ÆÖÐÐÄ(À¼ÖÝ°²öÎÓéÀÖ¹ÙÍøÑÛ¿ÆÒ½Ôº)½«ÔÙ½ÓÔÙÀ÷£¬Ò»Ö±ÍƽøÖصãѧ¿Æ½¨É裬Ìá*Ò½ÁÆ·þÎñ×ÛºÏÄÜÁ¦¡£


¡¡¡¡¡¾²Î¿¼ÎÄÏס¿

¡¡¡¡[1] Workshop DE.The Definition and Classification of Dry Eye Disease Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop[J]. Ocul Surf, 2007,5(2): 75-92.

¡¡¡¡[2]ÌïÓñ¾°,ÁõÑæ,×Þº£¶«,µÈ.ÉϺ£Êн­Äþ½ÖµÀ20Ëê¼°ÒÔÉÏÈËȺ¸ÉÑÛµÄÊ¢Ðв¡Ñ§ÊÓ²ì[J].ÖлªÑÛ¿ÆÔÓÖ¾,2009,45(6):486-491.

¡¡¡¡[3]Michael A,Leslie A,Anthony J, et al. Distribution of Aqueous-deficient and Evaporative Dry Eye in a Clinic-based Patient Cohort_ a Retrospective Study[J].Cornea,2012,31(5): 472-478.

¡¡¡¡[4]Ding J,Sullivan D.Aging and Dry Eye Disease[J]. Exp Gerontol,2012,47(7):483-490.

¡¡¡¡[5]½¯¸Û¸Û.MGD¶ÔÄêËêÏà¹ØÐÔ°×ÄÚÕϳ¬ÉùÈ黯ÊõºóÊÓ¾õÖÊÁ¿Ó°ÏìµÄÑо¿[D].¹ãÎ÷:¹ãÎ÷Ò½¿Æ´óѧ,2016.

¡¡¡¡[6]¶¡Ó±»Û.íú°åÏÙ¹¦Ð§ÕÏ°­»¼Õß½ÞëÈäÐÎòý¼ì³öÂÊÊÓ²ì[D].´óÁ¬:´óÁ¬Ò½¿Æ´óѧ,2014.

¡¡¡¡[7]Reiko A,Kouzo I,Shuji M, et al.Meibomian Gland Duct Distortion in Patients with Perennial Allergic Conjunctivitis[J].Cornea, 2010,29(8):858-860.

¡¡¡¡[8]Thode A,Latkany R.Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (mgd)[J].Springer International Publishing,2015,75(11):1177-1185.

¡¡¡¡[9]Dell S.Intense Pulsed Light for Evaporative Dry Eye Disease[J].Clin Ophthalmol,2017,20(11):1167-1173.

·µ»Ø ÔÚÏß×Éѯ
ÍøÕ¾µØͼ